Healthcare Providers and Services
Company Overview of SK3 Group Inc.
SK3 Group, Inc., through its subsidiaries, offers a range of healthcare services in the United States. The company provides hospice care services to individuals diagnosed with life-limiting illness and prefer to decline aggressive treatment. It also offers billing, reporting, and consulting services to medical offices, healthcare businesses, and home health agencies. The company also provides client institutions with personnel for the newborn, pediatric, intensive, and general adult areas of nursing and respiratory care. In addition, SK3 Group offers entry-level vocational training to students in the healthcare field; and provides respiratory therapy management services to acute hospitals an...
1365 North Courtenay Parkway
Merritt Island, FL 32953
Founded in 2000
Key Executives for SK3 Group Inc.
SK3 Group Inc. does not have any Key Executives recorded.
SK3 Group Inc. Key Developments
SK3 Group Announces First Sales of Medical Cannabis Product T-Hydrocan(Tm) RMC 40
Apr 22 14
SK3 Group Inc. announced that the first bottles of its new medicinal cannabis product, T-Hydrocan(TM) RMC 40, will be available from April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The 'RMC' designation indicates 'refined mixed cannabinoids.' T-Hydrocan(TM) RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis. T-Hydrocan(TM) RMC 40 is packaged eight tablets per bottle. The suggested retail price is $35.00 per bottle. T-Hydrocan(TM) RMC 40 was developed by Berkeley Bio-Organic Research Laboratories Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan(TM) product line will be T-Hydrocan(TM) Whole Plant 25 tablets and capsules.
David Hoye Appoints to the Board of Directors of SK3 Group Inc
Apr 15 14
David Hoye has been appointed to the Board of Directors of SK3 Group Inc. Hoye is co-founder of Berkeley Bio-Organic Research Laboratories, which was acquired in April of 2013.
SK3 Group Develops Cutting Edge Nutritional Supplement 'Alzatrex'
Mar 11 14
SK3 Group's Berkeley Bio Organic Research Laboratories has developed 'Alzatrex' (TM), an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that 9-THC, the main active ingredient in medical marijuana, decreases -amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain. The combination of a COX-2 inhibitor with medical cannabis also prevents marijuana-induced memory problems and 'brain fog' or 'haze' that is common.
Similar Private Companies By Industry
Recent Private Companies Transactions